Literature DB >> 18220847

Molecular mechanisms of cytochrome p450 induction: potential for drug-drug interactions.

Snehasis Jana1, Jyoti Paliwal.   

Abstract

The human liver cytochromes P450 (CYP P450s) are superfamily of hemoproteins responsible for catalyzing the oxidative metabolism of drugs and xenobiotics entering human body. Drug-drug/xenobiotic interactions are a major cause of therapeutic failures and adverse events. The concomitant administration of inducers with other drugs that are metabolized by CYP450 can result in their altered metabolism in the gastrointestinal tract and/ or liver. The clinical importance of such interactions includes auto induction leading to suboptimal or failed treatment. It is a major concern for the drug companies while developing new drugs. The present understanding of the mechanisms of induction of CYP P450s enzymes and their regulation has made considerable progress during last few years. However there are still gaps in our understanding on molecular aspects of CYP enzymes. Therefore, it remains the subject of intense scientific research to ascertain their in vivo function, and also better understand how the expression of CYP enzymes is regulated at the molecular level. This review analyzes and presents recent findings and concepts on xenosensors and their target genes. Emphasis is given to the molecular mechanisms and signaling pathways of CYP P450 mediated induction by xenobiotics and their potential for drug-drug interactions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18220847     DOI: 10.2174/138920307783018668

Source DB:  PubMed          Journal:  Curr Protein Pept Sci        ISSN: 1389-2037            Impact factor:   3.272


  10 in total

Review 1.  Drug interactions with herbal medicines.

Authors:  Shaojun Shi; Ulrich Klotz
Journal:  Clin Pharmacokinet       Date:  2012-02-01       Impact factor: 6.447

2.  Phenobarbital Treatment at a Neonatal Age Results in Decreased Efficacy of Omeprazole in Adult Mice.

Authors:  Yun-Chen Tien; Stephanie C Piekos; Chad Pope; Xiao-Bo Zhong
Journal:  Drug Metab Dispos       Date:  2017-01-06       Impact factor: 3.922

Review 3.  Clinically relevant drug-drug interactions between antiretrovirals and antifungals.

Authors:  Ramya Krishna Vadlapatla; Mitesh Patel; Durga K Paturi; Dhananjay Pal; Ashim K Mitra
Journal:  Expert Opin Drug Metab Toxicol       Date:  2014-02-12       Impact factor: 4.481

Review 4.  Sex differences in the expression of hepatic drug metabolizing enzymes.

Authors:  David J Waxman; Minita G Holloway
Journal:  Mol Pharmacol       Date:  2009-05-29       Impact factor: 4.436

5.  A Transcriptional Regulatory Network Containing Nuclear Receptors and Long Noncoding RNAs Controls Basal and Drug-Induced Expression of Cytochrome P450s in HepaRG Cells.

Authors:  Liming Chen; Yifan Bao; Stephanie C Piekos; Kexin Zhu; Lirong Zhang; Xiao-Bo Zhong
Journal:  Mol Pharmacol       Date:  2018-04-24       Impact factor: 4.436

6.  Exploring the Potential Toxicological Mechanisms of Vine Tea on the Liver Based on Network Toxicology and Transcriptomics.

Authors:  Fangyu Xiao; Jihua Qiu; Ying Zhao
Journal:  Front Pharmacol       Date:  2022-03-22       Impact factor: 5.810

Review 7.  Drug-Metabolizing Cytochrome P450 Enzymes Have Multifarious Influences on Treatment Outcomes.

Authors:  Yurong Song; Chenxi Li; Guangzhi Liu; Rui Liu; Youwen Chen; Wen Li; Zhiwen Cao; Baosheng Zhao; Cheng Lu; Yuanyan Liu
Journal:  Clin Pharmacokinet       Date:  2021-03-16       Impact factor: 6.447

8.  Cytochrome P450 2E1 gene polymorphisms/haplotypes and anti-tuberculosis drug-induced hepatitis in a Chinese cohort.

Authors:  Shaowen Tang; Xiaozhen Lv; Yuan Zhang; Shanshan Wu; Zhirong Yang; Yinyin Xia; Dehua Tu; Peiyuan Deng; Yu Ma; Dafang Chen; Siyan Zhan
Journal:  PLoS One       Date:  2013-02-27       Impact factor: 3.240

9.  Experimental nonalcoholic fatty liver disease in mice leads to cytochrome p450 2a5 upregulation through nuclear factor erythroid 2-like 2 translocation.

Authors:  Yizhe Cui; Qiuju Wang; Xiaochong Li; Xiuying Zhang
Journal:  Redox Biol       Date:  2013-08-24       Impact factor: 11.799

10.  A population-based analysis of the risk of drug interaction between clarithromycin and statins for hospitalisation or death.

Authors:  Bita Mesgarpour; Ghazaleh Gouya; Harald Herkner; Berthold Reichardt; Michael Wolzt
Journal:  Lipids Health Dis       Date:  2015-10-24       Impact factor: 3.876

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.